Michigami, T <br/><br/>
Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.  [electronic resource] 

 -  Cancer research  Feb 2001 
 - 1637-44 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acid Phosphatase--metabolism<br/>Animals<br/>Bone Marrow Cells--cytology<br/>Bone Neoplasms--metabolism<br/>COS Cells<br/>Carrier Proteins--biosynthesis<br/>Cell Communication--physiology<br/>Coculture Techniques<br/>Cyclooxygenase 2<br/>Female<br/>Glycoproteins--pharmacology<br/>Humans<br/>Interleukin-1--biosynthesis<br/>Isoenzymes--biosynthesis<br/>Membrane Glycoproteins--biosynthesis<br/>Membrane Proteins<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Neoplasm Transplantation<br/>Neuroblastoma--metabolism<br/>Osteoclasts--drug effects<br/>Osteoprotegerin<br/>Prostaglandin-Endoperoxide Synthases--biosynthesis<br/>RANK Ligand<br/>Receptor Activator of Nuclear Factor-kappa B<br/>Receptors, Cytoplasmic and Nuclear<br/>Receptors, Tumor Necrosis Factor<br/>Recombinant Proteins--pharmacology<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Tartrate-Resistant Acid Phosphatase<br/>Transplantation, Heterologous<br/>Tumor Cells, Cultured